By continuing to use our site, you agree to our Terms of Use and Privacy Policy.
No early effect of intrathecal rituximab in progressive multiple sclerosis (EFFRITE Clinical Trial)
According to the FDA prescribing information for both Ozempic and Wegovy, nausea, vomiting, diarrhea, abdominal pain, and constipation occur in a significant proportion of patients, particularly during dose escalation
For product-specific details, readers should consult manufacturer information directly Summary and Key Takeaways As consumers enter the New Year weight loss season for 2026, the GLP-1 supplement market presents both opportunities and challenges
In one study of patients who relapsed after a regimen of interferon without ribavirin, almost half achieved an SVR following re-treatment with interferon alfa and ribavirin for 24 weeks66